REDS — Redsense Medical AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK93.74m
- SEK77.72m
- SEK28.18m
- 21
- 22
- 30
- 11
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.5 | ||
| Price to Tang. Book | 3.93 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.76% | ||
| Return on Equity | -0.59% | ||
| Operating Margin | -0.91% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 14.44 | 9.36 | 14.34 | 24.97 | 28.18 | 33 | 40 | 16.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Redsense Medical AB (publ) is a Sweden-based company, which is primarily involved in the healthcare industry. The Company is active within the field of hemodialysis. It operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The Company's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.
Directors
- Bo Uneus CHM (57)
- Patrik Byhmer CEO (48)
- Brendan Kane DSL
- Jane Hurst OTH
- Susanne Olausson DRC
- Maria Alquist IND
- Klas Arildsson IND (58)
- Jorgen Hegbrant IND
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- July 11th, 2003
- Public Since
- June 17th, 2015
- No. of Employees
- 5
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 16,444,891
- Address
- Storgatan 36, HALMSTAD, 302 43
- Web
- https://redsensemedical.com/
- Phone
- +46 35106030
- Auditors
- KPMG AB
Upcoming Events for REDS
Q3 2025 Redsense Medical AB (publ) Earnings Release
Similar to REDS
Audientes A/S
AktieTorget Stock Exchange
BibbInstruments AB
AktieTorget Stock Exchange
Inhalation Sciences Sweden AB
AktieTorget Stock Exchange
Invent Medic Sweden AB
AktieTorget Stock Exchange
Micropos Medical AB (publ)
AktieTorget Stock Exchange
FAQ
What is the Redsense Medical AB (publ) share price?
As of Today at 22:53 UTC, shares in Redsense Medical AB (publ) are trading at SEK5.70. This share price information is delayed by 15 minutes.
How has the Redsense Medical AB (publ) share price performed this year?
Shares in Redsense Medical AB (publ) last closed at SEK5.70 and the price had moved by -18.57% over the past 365 days. In terms of relative price strength the Redsense Medical AB (publ) share price has underperformed the FTSE Global All Cap Index by -23.13% over the past year.
What are the analyst and broker recommendations for Redsense Medical AB (publ)?
There is no consensus recommendation for this security.
Find out moreWhat is the Redsense Medical AB (publ) dividend yield?
Redsense Medical AB (publ) does not currently pay a dividend.
Does Redsense Medical AB (publ) pay a dividend?
Redsense Medical AB (publ) does not currently pay a dividend.
When does Redsense Medical AB (publ) next pay dividends?
Redsense Medical AB (publ) does not currently pay a dividend.
How do I buy Redsense Medical AB (publ) shares?
To buy shares in Redsense Medical AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Redsense Medical AB (publ)?
As of the previous close price of SEK5.70, shares in Redsense Medical AB (publ) had a market capitalisation of SEK93.74m.
Where are Redsense Medical AB (publ) shares listed?
Here are the trading details for Redsense Medical AB (publ):
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: REDS
What kind of share is Redsense Medical AB (publ)?
Based on an overall assessment of its quality, value and momentum Redsense Medical AB (publ) is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Redsense Medical AB (publ) share price forecast for 2025?
The analyst consensus target price for shares in Redsense Medical AB (publ) is SEK34.50. That is 505.26% above the last closing price of SEK5.70.
Analysts covering Redsense Medical AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Redsense Medical AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Redsense Medical AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -25.61%.
As of the last closing price of SEK5.70, shares in Redsense Medical AB (publ) were trading -14.65% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Redsense Medical AB (publ) PE Ratio?
The Redsense Medical AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK5.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Redsense Medical AB (publ)?
Redsense Medical AB (publ)'s management team is headed by:
- Bo Uneus - CHM
- Patrik Byhmer - CEO
- Brendan Kane - DSL
- Jane Hurst - OTH
- Susanne Olausson - DRC
- Maria Alquist - IND
- Klas Arildsson - IND
- Jorgen Hegbrant - IND